How to buy shares in Hancock Jaffe Laboratories
Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Buy Hancock Jaffe Laboratories shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Is it a good time to buy Hancock Jaffe Laboratories stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Hancock Jaffe Laboratories share dividends
We're not expecting Hancock Jaffe Laboratories to pay a dividend over the next 12 months.
Have Hancock Jaffe Laboratories's shares ever split?
Hancock Jaffe Laboratories's shares were split on a 1:25 basis on 29 November 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hancock Jaffe Laboratories shares – just the quantity.
Hancock Jaffe Laboratories share price volatility
Over the last 12 months, Hancock Jaffe Laboratories's shares have ranged in value from as little as $4.99 up to $11.38. A popular way to gauge a stock's volatility is its "beta".
Hancock Jaffe Laboratories overview
Hancock Jaffe Laboratories, Inc. , a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe.
Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Hancock Jaffe Laboratories Inc.
Support, Risk & Stop-loss
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Is Hancock Jaffe Laboratories Inc. stock A Buy?
Hancock Jaffe Laboratories Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Insiders are positive buying more shares than they are selling in Hancock Jaffe Laboratories Inc
In the last 79 trades there were 7.38 million shares bought and 4.71 million shares sold. The last trade was done 163 days ago by Gray Robert who bough 1.04 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Component Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
HJLI Stock Summary
Hancock Jaffe Laboratories Inc's market capitalization of $7,135,019 is ahead of just 3.84% of US-listed equities.
Hancock Jaffe Laboratories, Inc. (HJLI) Company Bio
Hancock Jaffe Laboratories, Inc., a development stage medical device company, develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal, and peripheral arterial diseases in the United States and Europe.
What is Hancock Jaffe?
Hancock Jaffe Laboratories, Inc. is involved in developing and manufacturing bioprosthetic medical devices to treat cardiac and vascular diseases. Its product candidates consists of the porcine tissue based VenoValve, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; CoreoGraftÒ, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery and a porcine tissue based heart valve, is an ideal candidate for pediatric aortic/mitral valve replacement. Hancock Jaffe Laboratories, Inc. is based in IRVINE, United States.
Is ZacksTrade a separate company?
ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.